Foresite Capital Management IV, LLC
Position in PHVS — Pharvaris N.V.
CIK 1704132
West Hollywood, CA
Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$134,994,913
+$2,389,291 QoQ
Shares Held
4,778,581
0.0% QoQ
Ownership
6.84%
of shares outstanding
% of Portfolio
56.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Foresite Capital Management IV, LLC holds $237,082,218 across 8 Biotechnology names. PHVS ranks #1 (56.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
This page
|
4,778,581 | $134,994,913 | |
| 2 | CYTK |
Cytokinetics Inc
|
503,295 | $33,172,173 | |
| 3 | EIKN |
Eikon Therapeutics, Inc.
|
1,943,682 | $20,564,155 | |
| 4 | LYEL |
Lyell Immunopharma, Inc.
|
800,399 | $16,056,003 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
1,000,000 | $9,950,000 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
160,000 | $9,304,000 | |
| 7 | ALEC |
Alector, Inc.
|
3,887,200 | $8,357,480 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
156,901 | $4,683,494 |
All Filings in PHVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $134,994,913 | 4,778,581 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $132,605,622 | 4,778,581 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $119,225,595 | 4,778,581 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $77,626,225 | 4,410,581 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $69,246,121 | 4,410,581 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $84,307,378 | 4,397,881 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $81,448,756 | 4,397,881 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $80,724,455 | 4,293,854 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $93,337,638 | 4,038,842 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $113,289,518 | 4,038,842 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $78,125,801 | 3,743,450 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $56,675,833 | 3,743,450 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $26,153,988 | 3,246,926 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $36,527,917 | 3,246,926 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $24,903,922 | 3,246,926 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $71,757,064 | 3,246,926 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $59,155,028 | 3,261,926 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $46,939,115 | 3,261,926 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $57,833,947 | 3,261,926 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $60,769,681 | 3,261,926 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $91,268,689 | 3,261,926 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||